Prices re-read October 15, 2026Methodology v4.1How we score →
Compare Providers
Home / Provider scoring methodology

Released: ·Last reviewed: ·Methodology v4.1

Researched By
Medical Researcher · Western University of Health Sciences
Last medically reviewed: August 4, 2026 · This page is informational and does not constitute medical advice.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Provider scoring methodology

The detailed scoring rubric for telehealth providers, including points available per criterion and the missing-information rule.

Category detail

Each of the six categories in our methodology breaks into named criteria with points available and points awarded. Clinical safety (25 points) covers licensed review, eligibility screening, follow-up access, laboratory process, adverse-event handling, emergency limitations and clear contraindications. Pharmacy (20 points) covers pharmacy identification, independent license verification, 503A/503B accuracy, disclosed concentration and formulation, and the absence of misleading FDA-approval claims.

Missing-information rule

A provider does not receive full points when material information cannot be verified. We record each fact as Verified, Partially verified, Provider-reported, Not disclosed, Contradicted or Outdated.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.